At Lumetics, our mission is to provide innovative solutions for the science and technology industry. We strive to make the world a better place through cutting-edge research and development.
Our team consists of highly skilled professionals with years of experience in their respective fields. We work together to deliver the best possible results for our clients.
We offer a wide range of services, including product design, prototyping, testing, and consulting. Our goal is to help our clients bring their ideas to life and achieve their business objectives.
Analyze thousands of HPLC injections with ease. LINK combines automated metadata-driven analysis, powerful visualization tools, and integrated Empower report access to accelerate data review and decision-making.
Lumetics LINK™ combines machine learning and morphology fingerprinting to detect early signs of biologic product instability, identify critical particle populations, and uncover degradation mechanisms.
Connect your laboratory data ecosystem. Automated data capture, metadata integration, visualization, and reporting help teams spend less time managing data and more time generating insights.
Physicochemical Comparison of Kolliphor HS 15, ELP, and Conventional Surfactants for Antibody Stabilization in Biopharmaceutical Formulations – 2025, August: M. Zegota, A. Grabarek, E. Corradini, G. Schuster, A. Hawe (Coriolis)
The Strengths of Total Holographic Video Microscopy in Detecting Sub-Visible Protein Particles in Biopharmaceuticals: A Comparison to Flow Imaging and Resonant Mass Measurement – 2023, January: H. Rahn (AbbVie)
Overcoming Challenges with Submicron Particle Quantification Using a Combined Approach via Orthogonal Technologies – 2019, November: J, Conner (Pfizer)
Aspects of silicone separation in protein-silicone mixtures using S-factor-style electronic filter – 2019, July: E, Torres (Pfizer)
Separation, Characterization and Discriminant Analysis of Subvisible Particles in Biologics Formulations – 2019, March: Z, Akhunzada (BMS)
Contribution of Intravenous Administration Components to Subvisible and Submicron Particles Present in Administered Drug Product – 2019, March: M, Pollo., E, Torres (Pfizer)
S-Factor Optimization for MFI using Lumetics LINK – 2018, July: E, Torres (Pfizer)
Development of orthogonal NISTmAb size heterogeneity control methods – 2018, March: A, Turner (MedImmune, NIST)
Analytical Technique Comparisons using LINK – 2015, November: C. Merchant, D. Thomas (Lumetics)
Application of LINK for Automated Stability Studies – 2015, July: C. Merchant, D. Thomas (Lumetics)
— LUMETICS —
Ottawa, Ontario, Canada
Phone: 613.417.1839
Email: info@lumetics.com
Copyright © 2026 Lumetics - All Rights Reserved.
Powered by GoDaddy